39 results on '"Casaos, Joshua"'
Search Results
2. Current immunotherapy techniques in meningioma.
3. Basal BCL-2-Interacting Mediator of Cell Death (BIM) Responsiveness Correlates with Radiosensitivity in Meningioma
4. Combination Therapy with Mtor Inhibition and Ionizing Radiation in Meningioma Results In Superior Cytostatic Effect than Monotherapy
5. Captopril inhibits Matrix Metalloproteinase-2 and extends survival as a temozolomide adjuvant in an intracranial gliosarcoma model
6. The effect of renin-angiotensin system blockers on spinal cord dysfunction and imaging features of spinal cord compression in patients with symptomatic cervical spondylosis
7. RBIO-11. BASAL BCL-2-INTERACTING MEDIATOR OF CELL DEATH (BIM) RESPONSIVENESS CORRELATES WITH RADIOSENSITIVITY IN MENINGIOMA
8. Neurosurgical Implant-Based Strategy for Brain Cancer Therapy
9. Drug-Impregnated Polymer Delivery
10. Contributors
11. Supplementary Data from Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma
12. Functional Classification of Apoptotic Sensitivity in Meningioma
13. Safety Profile of Lumbosacropelvic Fixation in Patients Aged 60 Years or Older: Comparison Between S2-Alar-Iliac Screws and Conventional Iliac Screws
14. Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model
15. Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma
16. Disulfiram and Copper Combination Therapy Targets NPL4, Cancer Stem Cells and Prolongs Survival in Group 3 Medulloblastoma
17. Preclinical Efficacy of the Antiviral Drug Ribavirin in SHH and Group 3 Medulloblastoma
18. EXTH-61. COMBINATION OF DISULFIRAM AND COPPER INDUCES NPL4 AGGREGATION, TARGETS CD133-NESTIN CELLS AND EXTENDS SURVIVAL IN MEDULLOBLASTOMA GROUP 3 MODELS
19. Chapter 14 - Drug-Impregnated Polymer Delivery
20. Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma
21. Abstract 6268: Use of the anti-viral drug ribavirin as a radiosensitizing agent in nasopharyngeal carcinoma
22. Abstract B06: Repositioning the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
23. PDTM-06. DISULFIRAM-COPPER PROLONGS SURVIVAL AND REDUCES STEM-CELLNESS IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA THROUGH NUCLEAR SEQUESTRATION OF NPL4
24. Targeting of cyclin-dependent kinases in atypical teratoid rhabdoid tumors with multikinase inhibitor TG02.
25. 12. Angiotensin-II type-1 receptor blockade decreased T2 signal intensity in spinal cord compression in symptomatic cervical spondylotic myelopathy
26. Captopril as an Adjuvant to Temozolomide Prolongs Survival in a Rat Intracranial Gliosarcoma Model via Downregulation of Matrix Metalloproteinase-2
27. Genome‐wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types
28. The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
29. Abstract 2190: Repurposing the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
30. Absence of Ischemic Injury after Sacrificing the Superior Petrosal Vein during Microvascular Decompression
31. Diagnostic and therapeutic values of intraoperative electrophysiological neuromonitoring during resection of intradural extramedullary spinal tumors: a single-center retrospective cohort and meta-analysis
32. Hippocampal Transection Plus Tumor Resection as a Novel Surgical Treatment for Temporal Lobe Epilepsy Associated with Cerebral Cavernous Malformations
33. RARE-01. IN VIVO IMMUNOMODULATING EFFECT OF LXR-623 AND ITS SYNERGISM WITH CHECKPOINT BLOCKADE AGAINST CHORDOMAS IN A HUMANIZED MOUSE MODEL
34. 106 Sacrificing the Superior Petrosal Vein During Microvascular Decompression Does Not Increase Vascular Complications: Experience From One Institution
35. Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors
36. ICOS deficiency results in defective ILC2 expansion, impaired Th2 responses, and increased mortality after bleomycin-induced lung injury (HUM1P.264)
37. BTLA expression on CD4+ T cells negatively regulates the development of pulmonary fibrosis (HUM7P.319)
38. Absence of Ischemic Injury after Sacrificing the Superior Petrosal Vein during Microvascular Decompression.
39. The Bad, the Good and eIF3e/INT6.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.